Connect with us

Media OutReach

Hang Lung Expands Retail Portfolio in Wuxi, Marking Another Milestone of Their V.3 Strategy

Published

on

Long-term operating lease to expand Center 66’s retail area by nearly 40%

HONG KONG AND SHANGHAI – Media OutReach Newswire – 9 December 2025 – Hang Lung Properties Limited (SEHK Stock Code: 00101) (“Hang Lung” or the “Company”) today announced a partnership with Wuxi Liangxi City Development Group Co., Ltd.* to secure a long-term operating lease for a landmark commercial redevelopment project in central Wuxi. Expected to foster strong synergy with the adjacent Center 66, the latest project is a key initiative under Hang Lung V.3, the Company’s strategic blueprint for growth, and will further solidify Hang Lung’s leading position in Eastern China’s premium retail market. Formerly known as the Wuxi New World Department Store, the project will add approximately 47,000 square meters of commercial space, expanding the total retail footprint of the Center 66 complex by 38% to approximately 169,000 square meters.

Artist’s impression of Center 66 Expansion

Situated in a prime location in Wuxi central business district, the new project enjoys seamless connection to the subway. Hang Lung’s redevelopment plan envisions an urban living transformation for the new generation of young discerning consumers, featuring experiential retail and community connections and ensuring smooth connectivity and integration with the Center 66 complex. The transformed destination will introduce over 80 curated brands spanning food and beverage, fashion, and lifestyle experiences.

Artist’s impression of Center 66 Expansion
Artist’s impression of Center 66 Expansion

Mr. Weber Lo, Chief Executive Officer of Hang Lung Properties, said, “We are delighted to have secured this project, which marks another significant milestone for Hang Lung V.3 strategy that guides the next phase of our growth. Wuxi is one of strategically important markets for our expansion into the Chinese Mainland and deepening presence within the Yangtze River Delta. Its influence extends across Suzhou and Changzhou, while benefiting from synergistic connections with Shanghai, Nanjing, and Hangzhou. The project not only serves as a testament to Hang Lung’s core operational capabilities but also reflects the invaluable trust and support of Wuxi and Liangxi District governments.

Site Plan of Center 66 and its Expansion
Site Plan of Center 66 and its Expansion

“Beyond solidifying our market leadership, it will greatly enhance Center 66’s value as it continues to evolve into a premier destination in Southern Jiangsu Province, following its recent Phase 2 launch, which includes Center Residences and the upcoming Curio Collection by Hilton hotel. By placing customers at the heart of our business and deploying capital efficiently, we are dedicated to delivering attractive stakeholder returns in the long run, while injecting sustained vitality into Wuxi’s commercial development and urban renewal.”

Signing Ceremony for Phase III of Center 66, Wuxi
Signing Ceremony for Phase III of Center 66, Wuxi

The Hang Lung V.3 strategy focuses on elevating customer experience and expanding the Company’s presence in its existing markets through capital-efficient and highly selective reinvestments. These projects are designed to be immediately relevant to existing portfolio, enhancing their scale, visibility, and accessibility to maximize investment returns. Over the past year, the Company has successfully launched several V.3 initiatives, including the Plaza 66 Pavilion Extension, Spring City 66’s Shangyi Street, and the Westlake 66 Expansion.

Mr. Jiang Feng, Mayor of Wuxi, and Mr. Adriel Chan, Chair of Hang Lung, jointly witnessed the project’s signing ceremony in Wuxi. They are joined by Mr. Chen Shoubin, Secretary General of the Wuxi Municipal Government, and Mr. Weber Lo, Chief Executive Officer of Hang Lung.

*The official Chinese name is 无锡市梁溪城市发展集团有限公司.

Appendix

About Center 66 Expansion

Address: 319-339, 341 Zhongshan Road, Wuxi

Gross Floor Area (GFA) Breakdown:

(Sq. m.) Center 66 incl. Phase 2 Center 66 Expansion After completion

of Center 66 Expansion

Total 549,321 Approx. 55,000 Approx. 604,321
Retail 122,227 Approx. 47,000 Approx. 169,227
Office 137,543 137,543
Residences 101,153 101,153
Hotel 7,165 7,165
Car Parks/ Others 181,233 Approx. 8,000 Approx. 189,233

Recent Hang Lung V.3 Examples

Project City Asset Enhancement
Shangyi Street of Spring City 66 Kunming Create a must-visit streetscape destination for urban explorers and a photography hotspot
Pavilion Extension of Plaza 66 Shanghai Expand Plaza 66’s retail space by 13% based on leasable floor area
Westlake 66 Expansion Hangzhou Increase Westlake 66’s retail area by about 40% and street frontage by over 200%
Center 66 Expansion Wuxi Increase Center 66’s retail area by 38%

Hashtag: #HangLung

The issuer is solely responsible for the content of this announcement.

About Hang Lung Properties

Hang Lung Properties Limited (SEHK stock code: 00101) creates compelling spaces that enrich lives. Headquartered in Hong Kong and Shanghai, the Company manages a portfolio of over 3.5 million square meters of retail, office, residential, and hotel properties across Hong Kong and the Chinese Mainland.

The Company’s diverse portfolio in Hong Kong includes office towers and malls in prime districts, as well as luxury residential developments in prestigious areas. In the Chinese Mainland, under the signature “66” brand, the Company’s mixed-use and retail developments are regarded as premium landmarks, strategically located in the hearts of key cities of Shanghai, Shenyang, Jinan, Wuxi, Tianjin, Dalian, Kunming, Wuhan, and Hangzhou.

The Company is recognized for pioneering sustainability in the real estate industry, with an MSCI ESG rating of AA and inclusion on CDP “A List” for Climate Change. The Company powers 80% of its operating properties in the Chinese Mainland with renewable energy, with a net-zero commitment by 2050.

At Hang Lung Properties – We Do It Well.

For more information, please visit .

Media OutReach

ZenaTech Expands AI Drone Commercialisation as DaaS Contributes 93% of Q1 Revenue

Published

on

VANCOUVER, CANADA – Media OutReach Newswire – 22 July 2026 – ZenaTech (Nasdaq: ZENA) is combining AI-powered drone technology, enterprise software and professional services through its Drone-as-a-Service (DaaS) model, supporting commercial applications across engineering data collection, agriculture, warehouse management, facility inspection and property maintenance.

Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.

ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.

In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.

Acquisitions Support Service Network Expansion

ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.

In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.

By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.

Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.

The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.

Hashtag: #ZenaTech

The issuer is solely responsible for the content of this announcement.

About ZenaTech

ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.

Continue Reading

Media OutReach

A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation

Published

on

HONG KONG SAR – Media OutReach Newswire – 22 July 2026 – Gene Solutions – a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, announced that SPOT-MAS 10 has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This designation marks an important regulatory milestone for Gene Solutions and reflects the continued progress of SPOT-MAS as an AI-powered, multi-omic platform for early cancer detection.

SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation

The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.

SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.

Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.

The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.

For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.

Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.

Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.

For more information, visit https://spotmas.com.hk

Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04

Hashtag: #SPOTMAS

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys

Published

on

SINGAPORE – Media OutReach Newswire – 22 July 2026 – St Francis Methodist School International (SFMS) has released its latest academic results for students in the Western Australian Certificate of Education (WACE) programme. The outcomes reflect steady ATAR performance and a range of university placements through the school’s pre-university programmes.

St Francis Methodist International School pre university programmes

Overview of the WACE Curriculum at SFMS

SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.

SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.

Academic Outcomes and University Placements

In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.

In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.

Student Journeys and Holistic Development

Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.

Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.

Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.

These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational




The issuer is solely responsible for the content of this announcement.

About St Francis Methodist School International

Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.

Continue Reading